AUSTIN, Texas, Jan. 04, 2024 Lumos Pharma, Inc. , a late-stage biopharmaceutical company focused on therapeutics for rare diseases, has promoted Pisit “Duke” Pitukcheewanont, MD, known also.
/PRNewswire/ The thyroid gland disorder treatment market is expected to grow by USD 868.87 million from 2022 to 2027. In addition, the growth momentum of.
Operator: Good afternoon, and welcome to Lumos Pharma s Q2 2023 Financial Results Conference Call. Currently, all participants are in a listen-only mode.
Lumos Pharma, Inc.: Lumos Pharma Announces Departure of Chief Medical Officer finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.